HR

Henrijette Richter

Managing Partner at Sofinnova Partners

Copenhagen, Capital Region of Denmark

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Paris, France

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Investments
Finance
Lifesciences
Research
Biotechnology
Strategy
Funding
Start-ups
Mergers & Acquisitions
Business Strategy
Entrepreneurship
Business Development
Pharmaceutical Industry
Grants
Venture Capital

Education

Lists including Henrijette

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Asceneuron

Series A

Total Funding: $130M

Freya Biosciences

Series A

Total Funding: $38M

Nitrase Therapeutics

Series A

Total Funding: $45M

Mozart Therapeutics

Series A

Total Funding: $55M

NodThera

Series A

Total Funding: $95M

Comet Therapeutics

Series A

Total Funding: $29M

Twentyeight-Seven Therapeutics

Series A

Total Funding: $80M

Work Experience

SP
Sofinnova Partners

2014

  • Managing Partner

    2017

  • Partner

    2014 - 2017

MT
Mozart Therapeutics, Inc

2021

  • Board Member

    2021

NT
Nitrase Therapeutics

2020

  • Board Member

    2020

  • Board Member

    2020

MT
Muna Therapeutics

2021

  • Board Member

    2021

  • Board Member

    2021

TT
Twentyeight-Seven Therapeutics

2019

  • Board Member

    2019

  • Board Member

    2019

NL
NodThera Limited

2018

  • Board Member

    2019

  • Chair Of The Board Of Directors

    2018 - 2019

iT
iOmx Therapeutics AG

2016

  • Member of The Supervisory Board

    2019

  • Chair Of The Board Of Directors

    2016 - 2019

AS
Asceneuron SA

2015

  • Board Member

    2015

CT
Comet Therapeutics

2017 - 2021

  • Member Board Of Directors

    2017 - 2021

KD
Karolinska Development

2014 - 2017

  • Member Board of Directors

    2014 - 2017